AXIM® Biotechnologies Signs Exclusive Global Commercialization Agreement With Verséa(TM) Ophthalmics for Distribution and Sales of Novel Ophthalmic Diagnostics Solutions
We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy
. To find out more, read our
Privacy Policy
and our
Cookie Policy.